Evidence map›Paper›PMID 36288004›Full record

ArticleTropical medicine and infectious disease2022

Assessing the Impact of Relapse, Reinfection and Recrudescence on Malaria Eradication Policy: A Bifurcation and Optimal Control Analysis.

Hengki Tasman, Dipo Aldila, Putri A Dumbela, Meksianis Z Ndii, Fatmawati, Faishal F Herdicho, Chidozie W Chukwu

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Hengki TasmanDepartment of Mathematics, Universitas Indonesia, Depok 16424, Indonesia.ORCID 0000-0001-6615-3884
Dipo AldilaDepartment of Mathematics, Universitas Indonesia, Depok 16424, Indonesia.ORCID 0000-0001-9022-1701
Putri A DumbelaDepartment of Mathematics, Universitas Indonesia, Depok 16424, Indonesia.
Meksianis Z NdiiDepartment of Mathematics, University of Nusa Cendana, Kupang-NTT 85361, Indonesia.ORCID 0000-0002-9457-0703
FatmawatiDepartment of Mathematics, Faculty of Science and Technology, Universitas Airlangga, Jakarta 12920, Indonesia.ORCID 0000-0002-0418-6629
Faishal F HerdichoDepartment of Mathematics, Faculty of Science and Technology, Universitas Airlangga, Jakarta 12920, Indonesia.
Chidozie W ChukwuDepartment of Mathematics, Wake Forest University, Winston-Salem, NC 27109, USA.ORCID 0000-0002-2780-5357
University of Indonesia · IDAirlangga University · IDUniversity of Nusa Cendana · IDWake Forest University · US

Funding

University of Indonesia NKB-476/UN2.RST/HKP.05.00/2022
6 · The paper itself

Abstract

In the present study, we propose and analyze an epidemic mathematical model for malaria dynamics, considering multiple recurrent phenomena: relapse, reinfection, and recrudescence. A limitation in hospital bed capacity, which can affect the treatment rate, is modeled using a saturated treatment function. The qualitative behavior of the model, covering the existence and stability criteria of the endemic equilibrium, is investigated rigorously. The concept of the basic reproduction number of the proposed model is obtained using the concept of the next-generation matrix. We find that the malaria-free equilibrium point is locally asymptotically stable if the basic reproduction number is less than one and unstable if it is larger than one. Our observation on the malaria-endemic equilibrium of the proposed model shows possible multiple endemic equilibria when the basic reproduction number is larger or smaller than one. Hence, we conclude that a condition of a basic reproduction number less than one is not sufficient to guarantee the extinction of malaria from the population. To test our model in a real-life situation, we fit our model parameters using the monthly incidence data from districts in Central Sumba, Indonesia called Wee Luri, which were collected from the Wee Luri Health Center. Using the first twenty months' data from Wee Luri district, we show that our model can fit the data with a confidence interval of 95%. Both analytical and numerical experiments show that a limitation in hospital bed capacity and reinfection can trigger a more substantial possibility of the appearance of backward bifurcation. On the other hand, we find that an increase in relapse can reduce the chance of the appearance of backward bifurcation. A non-trivial result appears in that a higher probability of recrudescence (treatment failure) does not always result in the appearance of backward bifurcation. From the global sensitivity analysis using a combination of Latin hypercube sampling and partial rank correlation coefficient, we found that the initial infection rate in humans and the mosquito infection rate are the most influential parameters in determining the increase in total new human infections. We expand our model as an optimal control problem by including three types of malaria interventions, namely the use of bed net, hospitalization, and fumigation as a time-dependent variable. Using the Pontryagin maximum principle, we characterize our optimal control problem. Results from our cost-effectiveness analysis suggest that hospitalization only is the most cost-effective strategy required to control malaria disease.

Indexed as

backward bifurcationcost-effectivenesshysteresismalariaoptimal controlrecrudescencereinfectionrelapse

Identifiers

PMID36288004
PMCPMC9609641
OpenAlexW4298003514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.